QCG
CVS icon

Quadrant Capital Group’s CVS Health CVS Stock Holding History

Quadrant Capital Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Buy
27,322
+4,696
+21% +$362K 0.06% 277
2025
Q4 		$1.8M Buy
22,626
+2,261
+11% +$178K 0.05% 286
2025
Q3 		$1.54M Sell
20,365
-461
-2% -$31.6K 0.05% 331
2025
Q2 		$1.44M Sell
20,826
-2,160
-9% -$142K 0.05% 326
2025
Q1 		$1.56M Buy
22,986
+18,114
+372% +$1.08M 0.06% 258
2024
Q4 		$219K Sell
4,872
-1,869
-28% -$105K 0.02% 633
2024
Q3 		$424K Sell
6,741
-764
-10% -$44.6K 0.03% 390
2024
Q2 		$443K Sell
7,505
-3,562
-32% -$223K 0.03% 342
2024
Q1 		$883K Sell
11,067
-245
-2% -$18.7K 0.07% 211
2023
Q4 		$893K Sell
11,312
-314
-3% -$22.3K 0.08% 189
2023
Q3 		$812K Sell
11,626
-362
-3% -$25.6K 0.08% 181
2023
Q2 		$829K Buy
11,988
+862
+8% +$61.3K 0.08% 175
2023
Q1 		$827K Sell
11,126
-1,934
-15% -$162K 0.09% 170
2022
Q4 		$1.22M Sell
13,060
-442
-3% -$42.6K 0.14% 105
2022
Q3 		$1.29M Buy
13,502
+1,242
+10% +$123K 0.17% 87
2022
Q2 		$1.14M Sell
12,260
-170
-1% -$16.6K 0.15% 99
2022
Q1 		$1.26M Buy
12,430
+404
+3% +$42.4K 0.15% 90
2021
Q4 		$1.24M Sell
12,026
-745
-6% -$68.8K 0.15% 100
2021
Q3 		$1.08M Buy
12,771
+2,443
+24% +$205K 0.15% 104
2021
Q2 		$862K Buy
10,328
+823
+9% +$67.4K 0.13% 120
2021
Q1 		$715K Buy
9,505
+2,200
+30% +$160K 0.12% 126
2020
Q4 		$499K Buy
7,305
+1,735
+31% +$113K 0.09% 149
2020
Q3 		$325K Sell
5,570
-3,370
-38% -$210K 0.07% 180
2020
Q2 		$581K Sell
8,940
-5,082
-36% -$320K 0.13% 120
2020
Q1 		$833K Buy
14,022
+2,672
+24% +$178K 0.14% 124
2019
Q4 		$813K Buy
11,350
+1,975
+21% +$139K 0.1% 162
2019
Q3 		$573K Buy
9,375
+2,639
+39% +$156K 0.09% 199
2019
Q2 		$355K Buy
6,736
+697
+12% +$37.5K 0.06% 346
2019
Q1 		$318K Buy
6,039
+1,972
+48% +$122K 0.06% 337
2018
Q4 		$253K Buy
4,067
+739
+22% +$55.2K 0.07% 263
2018
Q3 		$246K Buy
3,328
+170
+5% +$12.2K 0.07% 186
2018
Q2 		$187K Sell
3,158
-217
-6% -$14.3K 0.07% 251
2018
Q1 		$197K Buy
3,375
+473
+16% +$33.9K 0.07% 242
2017
Q4 		$197K Buy
2,902
+3
+0.1% +$218 0.08% 221
2017
Q3 		$229K Buy
2,899
+147
+5% +$11.6K 0.09% 179
2017
Q2 		$173K Sell
2,752
-435
-14% -$34.3K 0.08% 209
2017
Q1 		$241K Buy
3,187
+700
+28% +$55.9K 0.11% 159
2016
Q4 		$191K Sell
2,487
-694
-22% -$56.2K 0.1% 152
2016
Q3 		$276K Buy
3,181
+501
+19% +$47.3K 0.18% 101
2016
Q2 		$247K Sell
2,680
-102
-4% -$10.2K 0.17% 105
2016
Q1 		$280K Buy
2,782
+384
+16% +$37.3K 0.18% 91
2015
Q4 		$228K Sell
2,398
-667
-22% -$65.3K 0.16% 120
2015
Q3 		$289K Buy
3,065
+75
+3% +$7.88K 0.2% 94
2015
Q2 		$307K Buy
+2,990
New +$305K 0.2% 92

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quadrant Capital Group's CVS Position: Q1 2026 in Review

Quadrant Capital Group increased its CVS Health (CVS) stake by 21% in Q1 2026, buying an estimated $362K and bringing the position to 27,322 shares worth $1.96M. The position accounts for 0.06% of the portfolio, ranked #277.

Quadrant Capital Group first reported a position in CVS in Q2 2015 and has held it in 44 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Quadrant Capital Group held 27,322 shares of CVS Health worth $1.96M as of Q1 2026.
  • Quadrant Capital Group bought 4,696 CVS Health shares in Q1 2026, an estimated $362K.
  • CVS Health made up 0.06% of Quadrant Capital Group's portfolio in Q1 2026, its #277 holding.
  • Quadrant Capital Group first reported a position in CVS Health in Q2 2015 and has held it in 44 quarters since.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.